Opaleye Management Inc.'s Form 4 filing
Eton Pharmaceuticals, Inc.ETON · filed Oct 8, 2024
- Accession no.
- 0001493152-24-040490
- Filed
- Oct 8, 2024
- Trade date
- Oct 4-8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market purchases total $434.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +15,000 | $6.77F3 | +$101,550 | 2,720,000 | Indirect | |
| Oct 4, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,852 | $6.77F3 | +$12,538.04 | 76,852 | Indirect | |
| Oct 7, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +10,000 | $7.22F4 | +$72,200 | 2,730,000 | Indirect | |
| Oct 7, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,248 | $7.22F4 | +$9,010.56 | 78,100 | Indirect | |
| Oct 8, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +30,000 | $7.03F5 | +$210,900 | 2,760,000 | Indirect | |
| Oct 8, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +3,970 | $7.03F5 | +$27,909.1 | 82,070 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.7532-$6.81 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 2 transactions in Table I.
- F4
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.20-$7.25 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 2 transactions in Table I.
- F5
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.8192-$7.34 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 2 transactions in Table I.